WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586 | Return to index | ||||||||
Order | Gene | Description | ref_hepatocyte | HepG2 | HepG2.C3A | HuH.7 | SNU475 | THLE | liver |
1 | HSP90AA1 | Heat shock protein HSP 90-alpha | [1] | -0.79[2] | -0.06[3] | -0.49[4] | -0.67[5] | -0.23[6] | -0.71[7] |
2 | CYP1A2 | Cytochrome P450 1A2 | [8] | -11.06[9] | -10.01[10] | -10.33[11] | -10.85[12] | -10.51[13] | -1.10[14] |
3 | CDC37 | Hsp90 co-chaperone Cdc37 | [15] | -0.90[16] | -1.79[17] | -1.08[18] | -2.57[19] | -1.23[20] | -1.43[21] |
4 | CYP1A1 | Cytochrome P450 1A1 | [22] | -4.61[23] | -6.44[24] | -2.44[25] | -6.25[26] | -6.04[27] | -5.25[28] |
5 | NQO1 | NAD(P)H dehydrogenase [quinone] 1 | [29] | 2.61[30] | 2.05[31] | 2.00[32] | 3.33[33] | 0.25[34] | -4.69[35] |
6 | CDKN1A | Cyclin-dependent kinase inhibitor 1 | [36] | 0.70[37] | -0.93[38] | -3.29[39] | -2.75[40] | 0.56[41] | -1.28[42] |
7 | KLF6 | Krueppel-like factor 6 | [43] | -0.98[44] | -1.06[45] | -1.88[46] | -2.06[47] | -1.16[48] | -0.18[49] |
8 | MYC | Myc proto-oncogene protein | [50] | 0.29[51] | -0.29[52] | -1.98[53] | -3.55[54] | -0.42[55] | -1.45[56] |
9 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | [57] | -1.07[58] | -1.64[59] | -0.72[60] | -1.31[61] | -0.04[62] | -0.64[63] |
10 | GCLC | Glutamate--cysteine ligase catalytic subunit | [64] | -0.50[65] | -0.38[66] | -1.26[67] | 0.19[68] | -1.77[69] | 0.96[70] |
11 | AIP | AH receptor-interacting protein | [71] | -0.66[72] | -0.84[73] | 0.69[74] | -0.15[75] | -0.83[76] | -1.15[77] |
12 | RELA | Transcription factor p65 | [78] | -0.01[79] | -0.75[80] | -0.28[81] | -0.82[82] | -0.15[83] | -0.33[84] |
13 | NFE2L2 | Nuclear factor erythroid 2-related factor 2 | [85] | 0.62[86] | 1.32[87] | 1.26[88] | -0.30[89] | 0.70[90] | 0.72[91] |
14 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | [92] | -0.21[93] | -0.04[94] | 1.56[95] | -0.95[96] | 0.67[97] | 1.65[98] |
15 | VEGFA | Vascular endothelial growth factor A | [99] | 1.08[100] | 2.17[101] | 1.11[102] | -0.32[103] | 1.14[104] | 1.33[105] |
16 | NRAS | GTPase NRas | [106] | 0.49[107] | 0.68[108] | 1.43[109] | 0.23[110] | 0.56[111] | 0.30[112] |
17 | CDKN1B | Cyclin-dependent kinase inhibitor 1B | [113] | -0.23[114] | -0.03[115] | 0.51[116] | -1.87[117] | -0.65[118] | -0.36[119] |
18 | CDK2 | Cyclin-dependent kinase 2 | [120] | -0.56[121] | -0.63[122] | 0.08[123] | -0.78[124] | 0.56[125] | -1.64[126] |
19 | HRAS | GTPase HRas | [127] | -1.15[128] | -2.09[129] | -2.55[130] | -1.71[131] | -1.17[132] | -2.11[133] |
20 | MAPK1 | Mitogen-activated protein kinase 1 | [134] | 1.57[135] | 1.47[136] | 1.63[137] | 1.09[138] | 1.49[139] | 2.32[140] |
21 | KRAS | GTPase KRas | [141] | -0.66[142] | -0.92[143] | 1.02[144] | 0.04[145] | 0.45[146] | 1.22[147] |
22 | FGF21 | Fibroblast growth factor 21 | [148] | -8.86[149] | -11.10[150] | -7.14[151] | -10.02[152] | -9.74[153] | -1.67[154] |
23 | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | [155] | 0.53[156] | -0.03[157] | 0.09[158] | -1.01[159] | 0.66[160] | 1.00[161] |
24 | NCOA7 | Nuclear receptor coactivator 7 | [162] | -1.03[163] | 0.23[164] | 0.08[165] | -0.09[166] | 1.03[167] | 1.28[168] |
25 | ARNT | Aryl hydrocarbon receptor nuclear translocator | [169] | 0.27[170] | -0.18[171] | 1.03[172] | 0.60[173] | 1.13[174] | 2.08[175] |
26 | EGFR | Epidermal growth factor receptor | [176] | -0.84[177] | -1.45[178] | 1.77[179] | -0.33[180] | 1.05[181] | 3.20[182] |
27 | AHR | Aryl hydrocarbon receptor | [183] | 0.98[184] | 1.04[185] | 2.39[186] | -0.22[187] | 1.45[188] | 3.14[189] |
28 | SRC | Proto-oncogene tyrosine-protein kinase Src | [190] | 2.88[191] | 2.63[192] | 1.96[193] | 1.64[194] | 1.57[195] | -0.30[196] |
29 | NRIP1 | Nuclear receptor-interacting protein 1 | [197] | 1.47[198] | 2.52[199] | 1.61[200] | 2.17[201] | 2.12[202] | 3.16[203] |
30 | RB1 | Retinoblastoma-associated protein | [204] | 1.08[205] | 1.34[206] | 2.23[207] | 1.51[208] | 2.59[209] | 2.03[210] |
31 | CYP1B1 | Cytochrome P450 1B1 | [211] | -7.19[212] | -6.87[213] | -2.42[214] | 0.74[215] | 4.11[216] | 1.56[217] |
32 | NCOR2 | Nuclear receptor corepressor 2 | [218] | 3.20[219] | 1.36[220] | 1.80[221] | 3.39[222] | 3.64[223] | 2.44[224] |
33 | E2F1 | Transcription factor E2F1 | [225] | 1.80[226] | 1.42[227] | 1.88[228] | 1.10[229] | 2.30[230] | -3.07[231] |
34 | EP300 | Histone acetyltransferase p300 | [232] | 2.58[233] | 1.93[234] | 3.16[235] | 1.81[236] | 2.62[237] | 3.30[238] |
35 | NF1 | Neurofibromin | [239] | 2.32[240] | 2.41[241] | 3.57[242] | 3.21[243] | 3.40[244] | 4.66[245] |
36 | CD36 | Platelet glycoprotein 4 | [246] | 1.19[247] | 0.28[248] | -4.47[249] | 2.42[250] | -5.83[251] | 3.63[252] |
37 | ESR1 | Estrogen receptor | [253] | -7.45[254] | [255] | -5.83[256] | -4.93[257] | -6.44[258] | 2.95[259] |
38 | PSRC1 | Proline/serine-rich coiled-coil protein 1 | [260] | 1.27[261] | 2.18[262] | 1.96[263] | 1.24[264] | 2.11[265] | -1.49[266] |
39 | RET | Proto-oncogene tyrosine-protein kinase receptor Ret | [267] | -5.71[268] | -7.23[269] | [270] | -6.73[271] | -3.02[272] | 1.14[273] |
40 | LPL | Lipoprotein lipase | [274] | [275] | [276] | -7.45[277] | -0.19[278] | -3.07[279] | 0.31[280] |
41 | PLAGL1 | Zinc finger protein PLAGL1 | [281] | 1.29[282] | 0.68[283] | 3.29[284] | -5.92[285] | 4.72[286] | 2.50[287] |
42 | AHRR | Aryl hydrocarbon receptor repressor | [288] | 1.25[289] | 0.13[290] | 0.76[291] | 4.03[292] | 3.17[293] | 1.28[294] |
43 | TNF | Tumor necrosis factor | [295] | 0.96[296] | -1.42[297] | -5.68[298] | -2.98[299] | -5.45[300] | -1.34[301] |
44 | HPGDS | Hematopoietic prostaglandin D synthase | [302] | [303] | [304] | [305] | -6.79[306] | -3.89[307] | 0.51[308] |
45 | PTGS2 | Prostaglandin G/H synthase 2 | [309] | [310] | -3.00[311] | -2.41[312] | 2.10[313] | 8.68[314] | 3.39[315] |
46 | MIR1281 | [316] | [317] | [318] | [319] | [320] | [321] | [322] | |
47 | CCL1 | C-C motif chemokine 1 | [323] | [324] | [325] | [326] | [327] | [328] | [329] |
48 | MIR1181 | [330] | [331] | [332] | [333] | [334] | [335] | [336] |